We compared ivermectin with diethylcarbamazine for the treatment of onchocerciasis in a double-blind, placebo-controlled trial. Thirty men with moderate to heavy infection and ocular involvement were randomly assigned to receive ivermectin in a single oral dose (200 micrograms per kilogram of body weight), diethylcarbamazine daily for eight days, or placebo. Diethylcarbamazine caused a significantly more severe systemic reaction than ivermectin (P less than 0.001), whereas the reaction to ivermectin did not differ from the reaction to placebo. Diethylcarbamazine markedly increased the number of punctate opacities in the eye (P less than 0.001), as well as the number of dead and living microfilariae in the cornea over the first week of therapy. Ivermectin had no such effect. Both ivermectin and diethylcarbamazine promptly reduced skin microfilaria counts, but only in the ivermectin group did counts remain significantly lower (P less than 0.005) than in the placebo group at the end of six months of observation. Analysis of adult worms isolated from nodules obtained two months after the start of therapy showed no effect of either drug on viability. Ivermectin appears to be a better tolerated, safer, and more effective microfilaricidal agent than diethylcarbamazine for the treatment of onchocerciasis.
This article has been cited by other articles:
CUPP, E. W., CUPP, M. S.
(2005). IMPACT OF IVERMECTIN COMMUNITY-LEVEL TREATMENTS ON ELIMINATION OF ADULT ONCHOCERCA VOLVULUS WHEN INDIVIDUALS RECEIVE MULTIPLE TREATMENTS PER YEAR. Am J Trop Med Hyg
73: 1159-1161
[Abstract][Full Text]
KRAIVICHIAN, K., NUCHPRAYOON, S., SITICHALERNCHAI, P., CHAICUMPA, W., YENTAKAM, S.
(2004). TREATMENT OF CUTANEOUS GNATHOSTOMIASIS WITH IVERMECTIN. Am J Trop Med Hyg
71: 623-628
[Abstract][Full Text]
Meinking, T. L., Taplin, D., Herminda, J. L., Pardo, R., Kerdel, F. A.
(1995). The Treatment of Scabies with Ivermectin. NEJM
333: 26-30
[Abstract][Full Text]
Schechter, C., Cagliano, S., Traversa, G., Taylor, H. R., Nash, S. D., Gilbert, E. M., Packer, M., Cleophas, T. J.M., Pohl, R., Balon, R., Denny, W. F., Sramek, J. J., Cutler, N. R., Solomon, D. A., Rothman, K. J., Michels, K. B.
(1995). The Use of Placebo Controls. NEJM
332: 60-62
[Full Text]
Rothman, K. J., Michels, K. B.
(1994). The Continuing Unethical Use of Placebo Controls. NEJM
331: 394-398
[Full Text]
Encarnacion, C. F., Giordano, M. F., Murray, H. W.
(1994). Onchocerciasis in New York City: The Moa-Manhattan Connection. Arch Intern Med
154: 1749-1751
[Abstract]
Taylor, H., Pacque, M, Munoz, B, Greene, B.
(1990). Impact of mass treatment of onchocerciasis with ivermectin on the transmission of infection. Science
250: 116-118
[Abstract]
Kumaraswami, V., Ottesen, E. A., Vijayasekaran, V., Devi, S. U., Swaminathan, M., Aziz, M. A., Sarma, G. R., Prabhakar, R., Tripathy, S. P.
(1988). Ivermectin for the Treatment of Wuchereria bancrofti Filariasis: Efficacy and Adverse Reactions. JAMA
259: 3150-3153
[Abstract]
Taylor, H. R., Murphy, R. P., Newland, H. S., White, A. T., D'Anna, S. A., Keyvan-Larijani, E., Aziz, M. A., Cupp, E. W., Greene, B. M.
(1986). Treatment of Onchocerciasis: The Ocular Effects of Ivermectin and Diethylcarbamazine. Arch Ophthalmol
104: 863-870
[Abstract]
Cupp, E., Bernardo, M., Kiszewski, A., Collins, R., Taylor, H., Aziz, M., Greene, B.
(1986). The effects of ivermectin on transmission of Onchocerca volvulus. Science
231: 740-742
[Abstract]
